Conversion From Cyclosporine Sandimmune to Cyclosporine Neoral in the Stable Renal Transplant Population

By Griffin P.J.A.   Moore R.H.   Jurewicz W.A.   Lord R.H.H.   Webley Y.   Jenkins J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 303-303

Elsevier

Access to resources Recommend Favorite

Conversion from the conventional cyclosporine formulation (sandimmune) to a new oral microemulsion (neoral) in stable liver transplant patients

By Dibo-Cohen J.M.   Conort O.   Conti F.   Bernard D.   Hazebroucq G.   Calmus Y.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1857-1857

Elsevier

Access to resources Recommend Favorite

Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method

By First M.R.   Weiskittel P.   Shah M.   Peddi V.R.   Canafax D.   Schroeder T.J.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 3955-3957

Elsevier

Access to resources Recommend Favorite

Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

By Baruch Y.   Assy N.   Kramsky R.   Enat R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1852-1853

Elsevier

Access to resources Recommend Favorite

Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients

By Arvind C.   Vathsala A.   Woo K.T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1681-1682

Elsevier

Access to resources Recommend Favorite